These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27614915)

  • 1. Plazomicin is effective in a non-human primate pneumonic plague model.
    Mega WM; Doyle-Eisele M; Cass RT; Kostrub CF; Sherwood RL; Metz MA; Cirz RT
    Bioorg Med Chem; 2016 Dec; 24(24):6429-6439. PubMed ID: 27614915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levofloxacin cures experimental pneumonic plague in African green monkeys.
    Layton RC; Mega W; McDonald JD; Brasel TL; Barr EB; Gigliotti AP; Koster F
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e959. PubMed ID: 21347450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule.
    Hewitt JA; Lanning LL; Campbell JL
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S51-S59. PubMed ID: 32435803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague.
    Campbell JL; Fay MP; Lanning LL; Hewitt JA
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S60-S65. PubMed ID: 32435805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
    Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
    Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cynomolgus macaque model for pneumonic plague.
    Warren R; Lockman H; Barnewall R; Krile R; Blanco OB; Vasconcelos D; Price J; House RV; Bolanowksi MA; Fellows P
    Microb Pathog; 2011 Jan; 50(1):12-22. PubMed ID: 21040776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).
    Davis KJ; Fritz DL; Pitt ML; Welkos SL; Worsham PL; Friedlander AM
    Arch Pathol Lab Med; 1996 Feb; 120(2):156-63. PubMed ID: 8712895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.
    Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK
    Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
    Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plazomicin: an investigational therapy for the treatment of urinary tract infections.
    Karaiskos I; Souli M; Giamarellou H
    Expert Opin Investig Drugs; 2015; 24(11):1501-11. PubMed ID: 26419762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92.
    Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Baze WB; Suarez G; Peterson JW; Chopra AK
    Microbes Infect; 2009 Feb; 11(2):205-14. PubMed ID: 19073275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic Analysis.
    Hammamieh R; Muhie S; Borschel R; Gautam A; Miller SA; Chakraborty N; Jett M
    PLoS One; 2016; 11(3):e0151788. PubMed ID: 27003632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.
    Gur D; Glinert I; Aftalion M; Vagima Y; Levy Y; Rotem S; Zauberman A; Tidhar A; Tal A; Maoz S; Ber R; Pass A; Mamroud E
    Front Microbiol; 2018; 9():741. PubMed ID: 29740404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
    Asempa TE; Avery LM; Kidd JM; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jul; 75(14):1048-1056. PubMed ID: 29895521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.
    Ponnusamy D; Fitts EC; Sha J; Erova TE; Kozlova EV; Kirtley ML; Tiner BL; Andersson JA; Chopra AK
    Infect Immun; 2015 May; 83(5):2065-81. PubMed ID: 25754198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.